6.17
Lifemd Inc stock is traded at $6.17, with a volume of 1.23M.
It is down -5.59% in the last 24 hours and up +3.70% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$6.535
Open:
$6.56
24h Volume:
1.23M
Relative Volume:
0.79
Market Cap:
$292.57M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-9.6406
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
-11.48%
1M Performance:
+3.70%
6M Performance:
+23.90%
1Y Performance:
+46.56%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
6.17 | 309.87M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-18-25 | Reiterated | BTIG Research | Buy |
Dec-10-24 | Initiated | Lake Street | Buy |
Dec-04-24 | Initiated | Mizuho | Neutral |
Aug-23-24 | Resumed | B. Riley Securities | Buy |
Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
Nov-30-23 | Initiated | Craig Hallum | Buy |
Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jul-03-23 | Initiated | H.C. Wainwright | Buy |
Mar-10-22 | Initiated | Colliers Securities | Buy |
Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LIFEMD (LFMD) ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
DEADLINE ALERT for AI, LFMD, SMLR, DOW: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
LifeMD, Inc. Shareholders Who Lost Money on Their - GlobeNewswire
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman - PR Newswire
October 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against LFMD - PR Newswire
LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - Morningstar
LifeMD, Inc. Class Action: Levi & Korsinsky Reminds LifeMD, - GlobeNewswire
LIFEMD DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages - GlobeNewswire
Hims & Hers Expands Personalized Care Access Via Telehealth Platform - Yahoo Finance
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. LawsuitLFMD - Morningstar
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and - The National Law Review
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming DeadlinesLFMD - PR Newswire
LFMD DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - GlobeNewswire
Deadline Alert: LifeMD, Inc. (LFMD) Shareholders Who Lost - GlobeNewswire
LifeMD Deadline: LFMD Investors with Losses in Excess of $50K Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm - Sahm
LIFEMD DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of LifeMD, Inc.(LFMD) Shareholders - GlobeNewswire
LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
LIFEMD, INC. (NASDAQ: LFMD) SHAREHOLDER ALERT Bernstein - GlobeNewswire
LifeMD, Inc. Class Action: The Gross Law Firm Reminds LifeMD, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 25, 2025LFMD - Morningstar
Securities Fraud Class Action Filed Against LifeMD, Inc. (LFMD)Levi & Korsinsky Reminds Investors of October 25, 2025 - ACCESS Newswire
LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - GlobeNewswire
CLASS ACTION REMINDER: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors to Inquire About a Securities Fraud Lawsuit by October 27, 2025 - Lelezard
Levi & Korsinsky Urges LifeMD, Inc. (LFMD) Shareholders to Act Before Lead Plaintiff Deadline October 25, 2025 - ACCESS Newswire
CLASS ACTION REMINDER: Berger Montague Advises LifeMD, Inc. (NASDAQ - MarketScreener
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025LFMD - Newsfile
LFMD DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages - GlobeNewswire
LIFEMD LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for InvestorsContact Levi & Korsinsky - FinancialContent
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - Morningstar
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Lost Money on LifeMD, Inc. (LFMD)? Contact Levi & Korsinsky Before October 25, 2025 to Join Class Action - ACCESS Newswire
LFMD Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Securities Fraud Class Action Against LifeMD, Inc. - Morningstar
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm - PR Newswire
Shareholders of LifeMD, Inc. Should Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights – LFMD - GlobeNewswire
Class Action Lawsuit Filed: LifeMD, Inc. (LFMD)Join by October 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
LFMD LAWSUIT ALERT: Levi & Korsinsky Notifies LifeMD, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WV News
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds LifeMD, Inc. (LFMD) Investors of October 25, 2025 Deadline - ACCESS Newswire
Investors SueWallSt Over LifeMD, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk - markets.businessinsider.com
Class Action Alert: Levi & Korsinsky Reminds LifeMD, Inc. (LFMD) Investors of October 25, 2025 Deadline - ACCESS Newswire
LifeMD Expands Novo Deal, Adds Ozempic At $499 - Yahoo Finance
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before - Bluefield Daily Telegraph
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):